Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-08 Sale | 2024-08-12 4:05 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 5,197 | $1,085 | $5,636,346 | 60,553 (Indirect Direct) | View |
| 2024-02-07 Sale | 2024-02-08 4:02 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 8,037 | $950.35 | $7,637,954 | 62,458 (Indirect Direct) | View |
| 2023-08-22 Sale | 2023-08-23 4:03 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 11,665 | $840.98 | $9,810,082 | 94,289 (Indirect Direct) | View |
| 2022-08-05 Sale | 2022-08-08 4:11 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 23,782 | $612.61 | $14,569,134 | 63,214 (Indirect Direct) | View |
| 2021-05-17 Sale | 2021-05-18 4:04 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 17,521 | $519.46 | $9,101,460 | 111,701 (Indirect Direct) | View |
| 2020-05-11 Sale | 2020-05-11 4:39 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 5,305 | $569.52 | $3,021,289 | 51,174 (Indirect Direct) | View |
| 2020-04-14 Sale | 2020-04-15 4:17 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 5,497 | $521.07 | $2,864,307 | 63,647 (Indirect Direct) | View |
| 2020-02-27 Sale | 2020-02-28 4:40 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 10,349 | $452.26 | $4,680,460 | 11,380 (Direct) | View |
| 2020-02-13 Sale | 2020-02-14 4:09 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 10,278 | $400.66 | $4,117,958 | 101,726 (Indirect Direct) | View |
| 2019-11-26 Sale | 2019-11-26 4:29 pm | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 4,006 | $364.07 | $1,458,467 | 124,101 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-13 Gift | 2024-08-14 4:01 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 500 | $0 | 60,053 (Direct) | View |
| 2024-08-12 Gift | 2024-08-12 4:05 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 900 | $0 | 60,553 (Direct) | View |
| 2024-08-02 Exercise | 2024-08-06 4:03 pm | N/A 2025-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 23,638 | $0 | 111,650 (Direct) | View |
| 2024-08-02 Tax Withholding | 2024-08-06 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 18,441 | $1,093 | 111,650 (Direct) | View |
| 2024-08-02 Exercise | 2024-08-06 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 23,638 | $555.67 | 111,650 (Direct) | View |
| 2024-02-26 Gift | 2024-02-28 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 1,020 | $0 | 61,438 (Direct) | View |
| 2024-02-02 Exercise | 2024-02-06 4:08 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 30,750 | $0 | 70,495 (Direct) | View |
| 2024-02-02 Exercise | 2024-02-06 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 30,750 | $399.66 | 70,495 (Direct) | View |
| 2024-02-02 Tax Withholding | 2024-02-06 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 22,713 | $956.65 | 70,495 (Direct) | View |
| 2023-12-08 Tax Withholding | 2023-12-12 4:05 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 809 | $843.79 | 65,517 (Direct) | View |
| 2023-12-11 Tax Withholding | 2023-12-12 4:05 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 725 | $844.09 | 65,517 (Direct) | View |
| 2023-12-08 Option Award | 2023-12-12 4:05 pm | N/A 2033-12-08 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 3,912 | $0 | 65,517 (Direct) | View |
| 2023-11-10 Gift | 2023-11-14 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 400 | $0 | 63,139 (Direct) | View |
| 2023-08-21 Exercise | 2023-08-23 4:03 pm | N/A 2024-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 50,000 | $0 | 94,289 (Direct) | View |
| 2023-08-21 Exercise | 2023-08-23 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 50,000 | $399.66 | 94,289 (Direct) | View |
| 2023-08-21 Tax Withholding | 2023-08-23 4:03 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 38,335 | $833.39 | 94,289 (Direct) | View |
| 2022-12-16 Option Award | 2022-12-20 4:08 pm | N/A 2032-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 5,164 | $0 | 67,582 (Direct) | View |
| 2022-11-08 Gift | 2022-12-13 4:11 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 330 | $0 | 62,418 (Direct) | View |
| 2022-12-09 Tax Withholding | 2022-12-13 4:11 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 466 | $753.28 | 62,418 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 4:11 pm | N/A 2023-12-13 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 95,000 | $0 | 63,214 (Direct) | View |
| 2022-08-04 Tax Withholding | 2022-08-08 4:11 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 71,218 | $613 | 63,214 (Direct) | View |
| 2022-02-18 Gift | 2022-08-08 4:11 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 335 | $0 | 63,214 (Direct) | View |
| 2022-08-04 Exercise | 2022-08-08 4:11 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 95,000 | $270.43 | 63,214 (Direct) | View |
| 2021-12-11 Tax Withholding | 2021-12-14 4:08 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 753 | $664.34 | 63,527 (Direct) | View |
| 2021-12-08 Option Award | 2021-12-10 5:35 pm | N/A 2031-12-08 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 15,420 | $0 | 76,774 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-06 4:10 pm | N/A 2022-12-14 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 72,500 | $0 | 61,354 (Direct) | View |
| 2021-12-03 Tax Withholding | 2021-12-06 4:10 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 50,352 | $632.45 | 61,354 (Direct) | View |
| 2021-11-29 Gift | 2021-12-06 4:10 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 4,605 | $0 | 61,354 (Direct) | View |
| 2021-12-03 Exercise | 2021-12-06 4:10 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 72,500 | $179.13 | 61,354 (Direct) | View |
| 2021-05-14 Exercise | 2021-05-18 4:04 pm | N/A 2021-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 52,500 | $0 | 111,701 (Direct) | View |
| 2021-05-14 Tax Withholding | 2021-05-18 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 34,979 | $516.69 | 111,701 (Direct) | View |
| 2021-05-14 Exercise | 2021-05-18 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 12,500 | $52.03 | 111,701 (Direct) | View |
| 2021-02-25 Gift | 2021-05-18 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 435 | $0 | 111,701 (Direct) | View |
| 2021-05-14 Exercise | 2021-05-18 4:04 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 40,000 | $179.13 | 111,701 (Direct) | View |
| 2020-02-26 Gift | 2020-12-11 4:05 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 750 | $0 | 57,115 (Direct) | View |
| 2020-12-09 Option Award | 2020-12-11 4:05 pm | N/A 2030-12-09 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 19,188 | $0 | 57,115 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-11 4:39 pm | N/A 2021-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 12,500 | $0 | 51,174 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-11 4:39 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 12,500 | $52.03 | 51,174 (Direct) | View |
| 2020-05-08 Tax Withholding | 2020-05-11 4:39 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 7,195 | $560.67 | 51,174 (Direct) | View |
| 2020-04-13 Exercise | 2020-04-15 4:17 pm | N/A 2021-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 13,079 | $0 | 63,647 (Direct) | View |
| 2020-04-13 Exercise | 2020-04-15 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 13,079 | $52.03 | 63,647 (Direct) | View |
| 2020-04-13 Tax Withholding | 2020-04-15 4:17 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 7,582 | $511.56 | 63,647 (Direct) | View |
| 2020-02-26 Exercise | 2020-02-28 4:40 pm | N/A 2021-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 25,000 | $0 | 65,346 (Direct) | View |
| 2020-02-26 Exercise | 2020-02-28 4:40 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 25,000 | $52.03 | 11,380 (Direct) | View |
| 2020-02-26 Tax Withholding | 2020-02-28 4:40 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 14,651 | $451.89 | 11,380 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-14 4:09 pm | N/A 2021-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 25,000 | $0 | 101,726 (Direct) | View |
| 2020-02-12 Exercise | 2020-02-14 4:09 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 25,000 | $52.03 | 101,726 (Direct) | View |
| 2020-02-12 Tax Withholding | 2020-02-14 4:09 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 14,722 | $402.34 | 101,726 (Direct) | View |
| 2019-12-11 Option Award | 2019-12-13 4:03 pm | N/A 2029-12-11 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 27,125 | $0 | 63,147 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-26 4:29 pm | N/A 2021-12-16 | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 10,000 | $0 | 124,101 (Direct) | View |
| 2019-11-25 Exercise | 2019-11-26 4:29 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 10,000 | $52.03 | 124,101 (Direct) | View |
| 2019-11-25 Tax Withholding | 2019-11-26 4:29 pm | N/A N/A | REGENERON PHARMACEUTICALS INC. | REGN | STAHL NEIL EVP Research and Development | 5,994 | $362.75 | 124,101 (Direct) | View |